Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Apeiron Biologics AG. (2/14/13). "Press Release: Austrian Research Promotion Agency (FFG) Provides Funds of Up to EUR 745,000.-- for Apeiron’s Project APN411".

Organisations Organisation Apeiron Biologics AG
  Group Apeiron (Group)
  Organisation 2 Österreichische Forschungsförderungsgesellschaft mbH (FFG)
  Group Austria (govt)
Products Product APN411 (Apeiron)
  Product 2 business development (state/region)
Index term Index term Apeiron–Austria (govt): grant, 201302– FFG funding of up to €745k for development of APN411
     


Funds are dedicated to support further development of a compound interfering with Cbl-b as a potential immune booster and cancer drug.


   
Record changed: 2017-04-02

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Apeiron (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top